Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSA Capital is a global venture capital and private equity firm that manages over $2 billion in assets across several flagship funds. The firm specializes in early-to-growth stage investments in technology-enabled sectors, with a significant and highly active focus on the life sciences, biotechnology, and healthcare industries. MSA Capital is known for its deep expertise in the Chinese market while maintaining a global investment footprint, backing innovative companies in areas such as gene sequencing, synthetic biology, and digital health. The firm provides strategic capital and operational support to its portfolio companies, leveraging a global network to facilitate cross-border growth and technological integration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MSA Investors.